Enhancing Early Detection of Metastatic Cutaneous Squamous Cell Carcinoma (CSCC): Integrating AI With Histopathological Assessments

Cutaneous squamous cell carcinoma (CSCC) patients at high risk for metastasis are insufficiently identified with current staging systems. Advances in digital pathology and artificial intelligence (AI) might assist by extracting detailed and reproducible predictive features from haematoxylin and eosin slides. We evaluated a multi-step convolutional neural network (CNN) as an assistive tool to provide detailed complementary histopathological variables towards identifying high-risk CSCC. Using a nested case-control design, we studied patients diagnosed with primary CSCC in the Netherlands from 2007 to 2018, with metastatic patients as cases and non-metastatic patients as controls. The dataset was divided into a development set (130 patients) and an evaluation set (244 patients). Four elaborative variables were derived from a CNN model for object detection and semantic segmentation, complementing six dermatopathologist-scored histopathological variables. Dermatopathologists involved were blinded to the outcomes. We assessed the efficacy of these variables using multivariable logistic regression (MR) models and odds ratios (OR) for metastatic CSCC on the evaluation set. The MR model fitting was assessed using the pairwise concordance index (C-index). The combined dermatopathologist-AI model yielded the highest C-index (0.92 [0.87-0.95]). Significant variables in the combined model included model-derived tumour area (OR 1.35 [1.00-1.84]) which complemented scored tumour diameter (OR 1.54 [0.75-3.17]) and model-derived nuclei density (OR 3.14 [1.08-9.17]) as a counterpart of scored tumour differentiation grades (OR 10.6 [3.01-37.0] and 11.5 [2.95-44.5]). The CNN model can derive detailed and reproducible histopathological variables associated with metastatic risk in CSCC, complementing the current pathologist-based assessment and enhancing the identification of high-risk CSCC.

Authors

Institutions

Publication Details

Journal
Experimental Dermatology
Published
2025-07-01
DOI
https://doi.org/10.1111/exd.70135
Primary Topic
Nonmelanoma Skin Cancer Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Enhancing Early Detection of Metastatic Cutaneous Squamous Cell Carcinoma (CSCC): Integrating AI With Histopathological Assessments

Catherine M. Chia, L Pijnenborg, Barbara Rentroia‐Pacheco, Dhruv Kumar et al.
Experimental Dermatology
Nonmelanoma Skin Cancer Studies
article

Enhancing Early Detection of Metastatic Cutaneous Squamous Cell Carcinoma (CSCC): Integrating AI With Histopathological Assessments

Catherine M. Chia, L Pijnenborg, Barbara Rentroia‐Pacheco, Dhruv Kumar, Jeffrey Damman, Selin Tokez, Edo M. Bramer, M. Wakkee, Antien L. Mooyaart, Loes M. Hollestein, Amir Almasi‐Hashiani
article en

Abstract

Cutaneous squamous cell carcinoma (CSCC) patients at high risk for metastasis are insufficiently identified with current staging systems. Advances in digital pathology and artificial intelligence (AI) might assist by extracting detailed and reproducible predictive features from haematoxylin and eosin slides. We evaluated a multi-step convolutional neural network (CNN) as an assistive tool to provide detailed complementary histopathological variables towards identifying high-risk CSCC. Using a nested case-control design, we studied patients diagnosed with primary CSCC in the Netherlands from 2007 to 2018, with metastatic patients as cases and non-metastatic patients as controls. The dataset was divided into a development set (130 patients) and an evaluation set (244 patients). Four elaborative variables were derived from a CNN model for object detection and semantic segmentation, complementing six dermatopathologist-scored histopathological variables. Dermatopathologists involved were blinded to the outcomes. We assessed the efficacy of these variables using multivariable logistic regression (MR) models and odds ratios (OR) for metastatic CSCC on the evaluation set. The MR model fitting was assessed using the pairwise concordance index (C-index). The combined dermatopathologist-AI model yielded the highest C-index (0.92 [0.87-0.95]). Significant variables in the combined model included model-derived tumour area (OR 1.35 [1.00-1.84]) which complemented scored tumour diameter (OR 1.54 [0.75-3.17]) and model-derived nuclei density (OR 3.14 [1.08-9.17]) as a counterpart of scored tumour differentiation grades (OR 10.6 [3.01-37.0] and 11.5 [2.95-44.5]). The CNN model can derive detailed and reproducible histopathological variables associated with metastatic risk in CSCC, complementing the current pathologist-based assessment and enhancing the identification of high-risk CSCC.

Experimental DermatologyVol. 34(7)
University of Helsinki (FI), Radboud University Nijmegen (NL), Erasmus MC (NL), Radboud University Medical Center (NL), Netherlands Comprehensive Cancer Organisation (NL)
Sanofi, Regeneron Pharmaceuticals, SkylineDx, Radboud Universiteit, Radboud Universitair Medisch Centrum, LEO Pharma, Hanarth Fonds, Sanofi Genzyme
Openalex Percentile: Top 77%
Nonmelanoma Skin Cancer Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.